Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-125318

Chief Financial Officer gave up 5,311 shares (to pay taxes)

  • Chief Financial Officer acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Roche Corleen M. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-06 Exercise or conversion : show line 1 in the form +12,500 41,257 D
2026-11-06 Shares withheld for taxes : show line 2 in the form −5,311 $8.04 $42,700 35,946 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-06 Exercise or conversion : show line 3 in the form Restricted Stock Units −12,500 87,505 D
Loading xslF345X06/tm2629446-1_4seq1.xml…